Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Balance Sheets

v3.22.2
Unaudited Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Assets    
Cash and cash equivalents $ 10,860 $ 21,729
Restricted cash 6,963 7,213
Accounts receivable, net 8,691 6,792
Inventories, net 10,489 5,245
Prepaid expenses and other current assets 2,948 2,940
Total Current Assets 39,951 43,919
Fixed assets, net 480 369
Right-of-use assets, operating lease 31 56
Intangible assets, net 10,823 11,586
Goodwill 18,614 18,614
Other assets 101 116
Total Assets 70,000 74,660
Current Liabilities    
Accounts payable 4,004 4,553
Accrued and other liabilities 2,215 1,879
Term loan, net 1,130 855
Operating lease liability 33 54
Total Current Liabilities 7,382 7,341
Non-current Liabilities    
Term loan, net 3,866 4,559
Line of credit, net 7,368 4,856
Deferred tax liability 24 24
Operating lease liability 0 5
Total Non-current Liabilities 11,258 9,444
Total Liabilities 18,640 16,785
Stockholders’ Equity    
Common Stock, $0.001 par value, 200,000,000 shares authorized, 29,364,712 and 29,146,367 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively 29 29
Series F Preferred Stock, $0.001 par value, 30,000 shares authorized, 0 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively 0 0
Additional paid-in capital 318,994 317,102
Accumulated deficit (267,663) (259,256)
Total Stockholders’ Equity 51,360 57,875
Total Liabilities and Stockholders’ Equity $ 70,000 $ 74,660